Researchers at the University of Queensland found that nearly 70% of suspected frontotemporal dementia patients were ...

Blood tests and the adoption of AI in cognitive decline screenings have opened the door to new avenues for testing cognitive ...

Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

It is based on initial research led by Dr Maura Malpetti, who received the Race Against Dementia Fellowship in 2021 from the ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms ...

A simple blood test is being rolled out across the UK as part of a new study to detect early signs of dementia decades before ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...